In this study, the authors show that ablation of Zc3h12a (which encodes Regnase-1) in CD8+ T cells improved the therapeutic efficacy of adoptively transferred, tumor-specific cells in mouse models of melanoma and leukemia. This evidence concerns the gene CD8A and leukemia.